FDA Approval Summary: Nadofaragene Firadenovec-vncg for Bacillus Calmette-Guérin-Unresponsive Non-Muscle-Invasive Bladder Cancer
FDA批准摘要:Nadofaragene Firadenovec-vncg用于治疗卡介苗无效的非肌层浸润性膀胱癌
期刊:Clinical Cancer Research
影响因子:10.2
doi:10.1158/1078-0432.CCR-24-2812
Colbert, Laronna; Jia, Yuxia; Sharma, Anurag; Hu, Jiang; Xu, Zhenzhen; Suzman, Daniel L; Das, Asha; Bross, Peter; Kluetz, Paul G; Fashoyin-Aje, Lola A